Workflow
Tango Therapeutics(TNGX)
icon
Search documents
Tango Therapeutics(TNGX) - 2021 Q1 - Quarterly Report
2021-05-14 19:59
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to________________ Not Applicable (Former name or former address, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: | | | Name of ...
Tango Therapeutics(TNGX) - 2020 Q4 - Annual Report
2021-03-31 20:26
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to ________________ Commission file number: 001-39485 BCTG ACQUISITION CORP. (Exact name of registrant as specified in its charter) | Delaware | 85-1195036 | | --- | ...
Tango Therapeutics(TNGX) - 2020 Q3 - Quarterly Report
2020-11-13 21:12
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 001-39485 85-1195036 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 12860 El Camino Real, Suite 300 San Diego, CA 92130 (Address of Principal Executive Offices) (Zip Code) (858) 400-3120 (Registrant's Telephone Number, Including Area Code) For the quarterly period ended S ...